MarketBeat | Stock Market News & Analysis

Get the Luke's Innovation Investor and his deep dive into Elon's new AI empire: https://www.marketbeat.com/y/yt1000/ InvestorPlace's Luke Lango joins MarketBeat's Bridget Bennett to break down Jensen Huang's new AI safety platform at NVIDIA and the 3 stocks to buy now that could benefit from the next phase of AI growth. We're on location in Las Vegas all this week for the Stansberry Research Conference, talking with some of the biggest stock market experts about every corner of AI growth and where else investors should be diversifying in this economic environment. In this interview, Luke explains why AI security and AI safety are suddenly a big deal, why companies may now have to test and put guardrails on their AI before they use it, and where he sees the best AI investments right now. If you're looking for the best AI stocks to buy now, or wondering how to invest in the AI boom, this stock market update is for you. View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Get the free report here now https://www.marketbeat.com/y/yt999/ MarketBeat analyst Thomas Hughes shares his 5 top stock picks for October. View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Get the FREE Report of the best stocks to buy and hold forever: https://www.marketbeat.com/y/yt998/ These 4 stocks all have really high short interest right now, and the shorts are betting big against them. But are they right? We break down each name and give you the bull case, the bear case, and where the real risk is hiding. We start with the basics: what short interest actually means, why it's not automatically a bad sign, and why days to cover matters just as much as the short interest number itself. Then we get into all 4 stocks, one by one, and break down whether the shorts have it right or whether there's still opportunity here. Two of these names could be in for a short squeeze if sentiment turns. The other two might have more room to fall. We'll tell you which is which. Video Chapters: 0:00 Introduction 0:00 What Short Interest and Days to Cover Actually Mean 0:00 Stock 1 0:00 Stock 2 0:00 Stock 3 0:00 Stock 4 View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

This could be bigger than ChatGPT: Get the special report on the stock behind Sam Altman's next project: https://www.marketbeat.com/y/yt996/ Apple just dropped its new iPhone lineup, and Meta unveiled new AI glasses at Connect. Josh Balin of Stansbury Research joins us to break down the less obvious ways to invest in the personal tech boom happening right now. From semiconductor royalties to satellite internet to a major new IPO, these are three stocks most investors aren't looking at. Chapters: 0:00 Introduction 3:16 The New Tech Boom, Then and Now 8:32 Stock 1 16:17 Stock 2 25:20 Stock 3 View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Get the Special Report on Where America's Biggest Capitalists Are Investing in Energy: https://www.marketbeat.com/y/yt997/ The US government is betting billions on stocks right now... but does that mean you should follow? Rob Spivey and Professor Joel Litman with Altimetry Research join me to explain why government-backed stocks have a history of letting investors down, and where they see the real opportunity instead. We start with two stocks to avoid, a rare earth miner and a lithium miner, both backed by government money. Rob and Joel break down what these companies would need to pull off just to justify their current prices. Then we get to three stocks they like right now, all benefiting from deregulation. One makes the giant turbines that AI needs for power, one is a bank positioned for a wave of mergers and more lending, and one is an oil and gas services company that now sells power straight to data centers. We also get into what the government's involvement means for long-term holders, how interest rates play into bank profits, and why the AI power build-out is far from over. Chapters: 00:00 Introduction 05:40 Stock 1 11:30 Stock 2 17:00 Stock 3 22:37 Stock 4 27:40 Stock 5 View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Get the FREE Report of the 10 Best AI Infrastructure Stocks to Buy This Year: https://www.marketbeat.com/y/yt994/ Thanks to LifeLock for sponsoring this video. Protect the life you're building with LifeLock. Visit https://lifelock.yt.link/afHD8Wl and use promo code LLSAVE for up to 35% off your first year. Terms apply. These stocks almost died... now some of them are up more than 100% in just one year. MarketBeat analyst Jeffrey Neal Johnson joins me to break down five comeback stocks that have made huge turnarounds, all thanks to a big pivot into AI. These are names you'll absolutely recognize. A few of them were on their deathbed not long ago. We cover a former phone maker that now powers the operating systems inside smart cars, a telecom company positioning cell towers to become tiny AI data centers, a classic calculator company making the chips that help the big AI chips run, a glass company that's been around since the 1800s and now solves one of AI's biggest bottlenecks, and an internet backbone company building cybersecurity right into the router. We also dig into the big question for all five... is the turnaround already priced in, or is there still a long runway ahead? Video Chapters: 00:00 Introduction 01:22 Stock 1 07:53 Stock 2 14:40 Stock 3 19:00 Stock 4 23:50 Stock 5 View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Get the latest stock market analysis as we break down key movers and upcoming catalysts to help you navigate the week ahead. Join Bridget Bennett and our analyst team as we review the session's action and set the stage for upcoming market events. We examine the latest Meta Platforms earnings to gauge sentiment for big tech, while also looking at the specific AMD EPS estimates driving volatility in the semiconductor space. Our team also takes a closer look at the recent performance of Bloom Energy stock and other names on our radar. Whether you are tracking momentum plays or looking for long-term opportunities, we provide the data you need to make informed decisions at market close. Subscribe for weekly stock market analysis breakdowns, and leave a ticker symbol in the comments if you want us to cover it next time. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Get the FREE Report on 7 Stocks to Buy and Hold Forever: https://www.marketbeat.com/y/yt991/ Three biotech stocks. Three major FDA catalysts. And the results could send these stocks soaring or send them tumbling. MarketBeat analyst Chris Markoch joins Bridget to break down Kodiak Sciences, Capricor Therapeutics, and Invivyd, three small-cap biotechs all approaching binary, high-stakes FDA events. Chris walks through why FDA catalysts move biotech stocks more than almost any other sector, what separates a late-stage phase three trial from an early one, and how to think about institutional ownership and short interest as signals for volatility. The two dig into each company's pipeline, what their trials are actually testing, the price action leading into their next catalyst, and analyst price targets that in some cases point to massive upside if results come in positive. View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. Video Chapters: 0:00 Intro 5:02 Stock 1 10:35 Stock 2 16:00 Stock 3 DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Want to know what stocks to buy now? Get the FREE Report on the Best Space Stocks to Buy Now: https://www.marketbeat.com/y/yt992/ Space stocks are crashing, and insiders are selling out. But is that actually a warning sign, or the setup for the next opportunity? MarketBeat analyst Thomas Hughes joins Bridget to break down four space stocks all showing recent insider selling, and why the picture behind that selling might be more bullish than it looks. Thomas walks through the difference between meaningful insider selling and routine compensation-driven selling, what to watch for with prearranged trading plans, and why institutions and analysts are buying the dip even as insiders cash out. The two dig into each stock's chart, catalysts, and timeline to profitability, from rocket launches to lunar infrastructure to satellite constellations to global mobile connectivity. View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.

Many retail investors looking for the next best stocks to buy have turned to rare earth stocks and other critical materials. Tungsten just became the newest name in the critical materials race, and the deal behind it stretches from Kazakhstan to Washington. Paul Mann, Executive Chairman of Skyline Builders, joins Bridget to break down why his company is betting on a massive tungsten mine in Kazakhstan, and why the US government is reportedly putting up to $1.6 billion behind it. He details the new stock ticker KAZR and why retail investors and Wall Street investors are both starting to pay attention. Right now, 87% of the world's tungsten supply comes from China, North Korea, and Russia. Tungsten is essential for missiles, tanks, armored plating, electronics, and nuclear applications, and the US has almost no domestic production. Paul explains how this new Kazakhstan mine could become one of the largest tungsten sources outside of those three countries, why the US and Kazakhstan have been deepening ties for years, and what the reverse merger process looks like for investors trying to get in early. Paul also shares his background in critical materials investing, including his roles with ASP Isotopes and Tungsten Resources, and why he believes supply shortages are coming across multiple critical materials over the next decade. View Bridget's Buys here: https://www.marketbeat.com/bridget 📲 Text 'YouTube' to 68285 for FREE SMS breaking news alerts on top stocks. Disseminated on behalf of Skyline Builders Group (NASDAQ:KAZR). Read the full report: https://tomorrowinvestor.com/kaz-resources-pentagon-races-to- replenish-munitions-stockpiles/ Learn more at the company website: https://www.kazresources.com Disclosure/Disclaimer: We are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. This video was conducted on behalf of Skyline Builders Group Holding Limited and was funded by Think Ink Marketing. For our full disclaimer, please visit: https://tomorrowinvestor.com/kaz-resources-pentagon-races-to-replenish-munitions- stockpiles/#disclaimer DISCLAIMER: MarketBeat's videos are for educational and informational purposes only and do not constitute financial, legal, or tax advice. We are not registered investment advisers, and nothing herein is a recommendation to buy, sell, or hold any security or strategy. Investing involves risk—including the potential loss of principal—so always perform your own due diligence and consult a licensed professional before acting. All opinions are those of the presenters and may change without notice. Presenters and MarketBeat personnel may own or trade the securities discussed. Past performance is not indicative of future results; any examples or case studies shown are illustrative and not typical. Some links or promotions mentioned may be affiliate partnerships that compensate MarketBeat at no additional cost to you. MarketBeat and its representatives accept no liability for any losses arising from reliance on this content.